The Efficacy and Safety of Zaoren Anshen Capsule in Combination with Zolpidem for Insomnia: A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Trial

唑吡坦 安慰剂 失眠症 医学 不利影响 胶囊 随机对照试验 内科学 药丸 麻醉 药理学 植物 替代医学 病理 生物
作者
Xiangzhen Zhu,Ming Tao,Haoyu Hu,Jingfang Gao,Jiong Chen,Tiaotiao Lu,Xiaole Wang,Wei Kong,Lijun Lv,Minjun Wei
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2022: 1-9 被引量:3
标识
DOI:10.1155/2022/5867523
摘要

Insomnia is the most common sleep disorder with high rate of prevalence, persistence, and leads to negative consequences. The mainstays of insomnia treatment have limitations due to either the side effects of hypnotics or limited accessibility to cognitive behavioral therapy. This study aims to compare the efficacy and safety of the traditional Chinese medicine (TCM) Zaoren Anshen capsule alone or as an adjunct treatment with different doses of the nonbenzodiazepine medication zolpidem tartrate in treating insomnia.This randomized, double-blind, multicentre placebo control trial was conducted in 131 patients with chronic insomnia. The patients were randomly assigned to one of the following four regimen groups: Group ZA + Z5 : Zaoren Anshen capsule and 5 mg zolpidem tartrate (n = 32); Group Z5: 5 mg zolpidem tartrate and placebo capsule (n = 35); Group Z10 : 10 mg zolpidem tartrate and placebo capsule (n = 32); Group ZA : Zaoren Anshen capsule and placebo pill (n = 32). The drugs were administered for 4 weeks. All patients were evaluated by the Insomnia Severity Index (ISI) at 0, 2, 4, 5, and 6 weeks, and adverse events were recorded.There are significant differences in the comparison between the four groups at each treatment stage (P < 0.05). Repeated measurement analysis of variance (ANOVA) of ISI scores in each treatment stage of the four groups exhibits significant differences in time effect, intergroup effect, and interaction effect (P < 0.05). After four weeks of drug administration, the treatment efficacy is similar in Groups ZA + Z5 and Z10 (93%) and in Groups Z5 and ZA (62% and 65%, respectively). Groups ZA + Z5 and Z10 present significantly lower ISI scores compared with Groups Z5 and ZA (P < 0.05), which indicates better treatment response of Groups ZA + Z5 and Z10. No significant difference was observed in the incidence of adverse events between the groups.Zaoren Anshen capsule can effectively treat insomnia disorder either alone or in combination with zolpidem tartrate. A preferred combination of TCM Zaoren Anshen capsule with zolpidem can provide a magnified therapeutic efficacy with fewer side effects than zolpidem-only management, clinical trial registration number: Chinese Clinical Trial Registry ChiCTR-IPR-1600969.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
所所应助啾啾采纳,获得10
1秒前
VDC发布了新的文献求助10
1秒前
qjq琪发布了新的文献求助10
2秒前
小生完成签到,获得积分10
2秒前
2秒前
111完成签到,获得积分10
3秒前
jie发布了新的文献求助10
4秒前
cadcae发布了新的文献求助30
4秒前
5秒前
5秒前
一澜完成签到,获得积分10
5秒前
5秒前
yyybxqmz发布了新的文献求助10
5秒前
颜靖仇发布了新的文献求助10
5秒前
6秒前
6秒前
搜集达人应助523165采纳,获得20
6秒前
6秒前
liubingsai完成签到,获得积分10
7秒前
7秒前
谢婉婷发布了新的文献求助10
7秒前
7秒前
云云完成签到,获得积分10
8秒前
科研通AI2S应助dazuang采纳,获得10
8秒前
Aganlin完成签到,获得积分0
8秒前
双shuang发布了新的文献求助10
8秒前
ky一下完成签到,获得积分20
9秒前
qqq发布了新的文献求助10
10秒前
JACK发布了新的文献求助10
10秒前
Hz完成签到,获得积分10
10秒前
10秒前
月亮完成签到,获得积分10
10秒前
11秒前
皓轩发布了新的文献求助10
12秒前
ZK999发布了新的文献求助10
12秒前
Hang发布了新的文献求助10
12秒前
JamesPei应助有点抽风采纳,获得50
12秒前
12秒前
Aganlin发布了新的文献求助10
13秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Musculoskeletal Pain - Market Insight, Epidemiology And Market Forecast - 2034 2000
Animal Physiology 2000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Am Rande der Geschichte : mein Leben in China / Ruth Weiss 1500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3743782
求助须知:如何正确求助?哪些是违规求助? 3286427
关于积分的说明 10050288
捐赠科研通 3002956
什么是DOI,文献DOI怎么找? 1648631
邀请新用户注册赠送积分活动 784708
科研通“疑难数据库(出版商)”最低求助积分说明 750802